News


All News

Newer drugs are available to combat potentially serious infections including methicillin-resistant Staphylococcus aureus (MRSA), says Kenneth J. Tomecki, M.D., vice-chairman, department of dermatology, Cleveland Clinic. Colonization, mainly of the anterior nares, remains a major risk factor for MRSA.

A facial rejuvenation device that delivers fractional bipolar radiofrequency (RF) energy via microneedling directly into the dermis tightens skin and achieves measurable lifting and volume increase the likes of which have never been seen by any other devices on the market, said Lori Brightman, M.D., at the 2012 meeting of the American Society for Laser Medicine and Surgery.

Male rosacea patients present with larger facial telangiectasias and more severe erythema because they tend to minimize skin problems and delay treatment, but a treatment plan focused on laser surgery can produce excellent outcomes, and the lack of ongoing aftercare is appealing to many male patients, says Tina S. Alster, M.D.

Dermatologists have the highest level of job satisfaction of 25 medical specialties, according to a national survey conducted by Medscape titled Physician Compensation Report 2012. Dermatologists also are among the better compensated, particularly when their more-varied pattern of hours worked are taken into consideration.

I can't tell you how many wonderful things I've heard from medical administrators and non-physician consultants that will result from the adoption of the electronic medical record (EMR). But like most of us, I've been taught to believe that if something sounds too good to be true, it probably is.

Two important Washington developments regarding sunscreen have taken place this summer, but neither will do much to help adults who need guidance in protecting themselves during this year's sunbathing season. Early in May, the Food and Drug Administration announced it is delaying until December implementation of new sunscreen rules that had been scheduled to take effect in June.

A single intracellular molecule, activator protein-1 (AP-1), appears to initiate the signaling cascade for vascular remodeling that results in varicose veins. Assuming that these findings on the mechanisms of the disease in a mouse model translate into humans, they offer new targets for therapeutic intervention that go beyond current surgical options, a researcher says.

Lauding his years of service and contributions, the National Psoriasis Foundation awarded its inaugural Lifetime Achievement Award to Mark G. Lebwohl, M.D., professor and chairman of dermatology, Mount Sinai School of Medicine, New York.